Medicare will start covering obesity drugs for the first time, which could open access to millions of seniors and spur more ...

Novo Nordisk said it currently expects an estimated negative low single-digit impact to global sales growth in 2026 after the ...

Shares in Novo Nordisk fell as much as 3% on Friday after the Danish drugmaker and U.S. rival Eli Lilly agreed with the U.S.

U.S. President Donald Trump, Eli Lilly and Novo Nordisk unveiled a deal on Thursday to slash the prices of popular GLP-1 ...

Certain GLP-1 weight loss medications will be available for as little as $149 per month, a sharp drop from the current ...

Pedersen and Maggie Fick COPENHAGEN (Reuters) -Shares in Novo Nordisk and Eli Lilly slipped on Friday after both agreed with ...

Novo Nordisk A/S & Eli Lilly and Company cut prices for top diabetes drugs, boosting accessibility and potential revenue.

A fierce bidding war could be costly for Novo Nordisk. The stock price for Danish drugmaker Novo Nordisk (NYSE: NVO) is down more than 8% since last Friday's close. What's going on with this former ...

Novo Nordisk's experimental drug, CagriSema, shows promise beyond weight loss, potentially offering significant ...

The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...

Pfizer and Novo Nordisk have locked horns in a bidding war over Metsera – a US-based biotech in the process of developing new ...